About Rite Aid (NYSE:RAD)
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. This segment also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; offers integrated mail-order and specialty and compounding pharmacy services; and provides infertility treatment, as well as drug benefits under the federal government's Medicare Part D program. As of June 20, 2017, the company operated approximately 4,500 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:RAD
CUSIP76775410
Phone717-761-2633
Debt
Debt-to-Equity Ratio2.11%
Current Ratio1.37%
Quick Ratio0.85%
Price-To-Earnings
Trailing P/E Ratio-79.00
Forward P/E Ratio39.50
P/E GrowthN/A
Sales & Book Value
Annual Sales$21.53 billion
Price / Sales0.08
Cash Flow$0.3098 per share
Price / Cash5.10
Book Value$1.50 per share
Price / Book1.05
Profitability
EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins3.60%
Return on Equity-8.25%
Return on Assets-0.71%
Miscellaneous
Employees87,000
Outstanding Shares1,067,650,000
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid (NYSE:RAD) posted its quarterly earnings data on Thursday, April, 12th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The company earned $5.39 billion during the quarter, compared to analysts' expectations of $5.75 billion. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The business's revenue for the quarter was down 8.6% on a year-over-year basis. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid issued an update on its FY19 earnings guidance on Thursday, April, 12th. The company provided earnings per share guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.03. The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $21.73 billion.
What price target have analysts set for RAD?
8 brokerages have issued 1-year price objectives for Rite Aid's shares. Their predictions range from $1.50 to $4.70. On average, they anticipate Rite Aid's share price to reach $2.3063 in the next year. View Analyst Ratings for Rite Aid.
Are investors shorting Rite Aid?
Rite Aid saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 163,994,755 shares, an increase of 11.9% from the March 15th total of 146,518,471 shares. Based on an average trading volume of 23,947,474 shares, the days-to-cover ratio is presently 6.8 days. Currently, 15.5% of the shares of the company are short sold.
Who are some of Rite Aid's key competitors?
Some companies that are related to Rite Aid include Dicks Sporting Goods (DKS), Michaels Companies (MIK), Aaron's (AAN), Sprouts Farmers Market (SFM), Performance Food Group (PFGC), Tech Data (TECD), PriceSmart (PSMT), Groupon (GRPN), Jack in the Box (JACK), Lithia Motors (LAD), Li-Ning (LNNGY), Boohoo.com (BHOOY), Bed Bath & Beyond (BBBY), Domino's Pizza Group (DPUKY), The Cheesecake Factory (CAKE), Tempur Sealy International (TPX), Signet Jewelers (SIG) and Greene King (GKNGY).
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, Chairman & CEO (Age 55)
- Mr. Darren W. Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
- Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
- Mr. Kermit R. Crawford, Pres & COO (Age 59)
- Mr. Douglas Elwood Donley, Sr. VP & Chief Accounting Officer (Age 56)
Has Rite Aid been receiving favorable news coverage?
Press coverage about RAD stock has been trending somewhat positive on Saturday, Accern reports. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rite Aid earned a coverage optimism score of 0.19 on Accern's scale. They also assigned headlines about the company an impact score of 46.43 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $1.58.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $1.71 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 87,000 workers across the globe.
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
Rite Aid (NYSE:RAD) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Rite Aid in the last 12 months. Their average twelve-month price target is $2.3063, suggesting that the stock has a possible upside of 45.97%. The high price target for RAD is $4.70 and the low price target for RAD is $1.50. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 1.88 | 1.88 | 2.00 | 2.00 |
| Ratings Breakdown: | 2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $2.3063 | $2.3063 | $2.7722 | $3.4111 |
| Price Target Upside: | 45.97% upside | 10.88% upside | 33.28% upside | 74.04% upside |
Rite Aid (NYSE:RAD) Consensus Price Target History
Rite Aid (NYSE:RAD) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
Rite Aid (NYSE:RAD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 47.46%
Rite Aid (NYSE RAD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/3/2017 | Myrtle S Potter | Director | Sell | 28,189 | $2.09 | $58,915.01 | |  |
| 6/15/2016 | Douglas E Donley | SVP | Sell | 34,106 | $7.77 | $265,003.62 | 82,885 | |
| 7/9/2015 | Tony Montini | EVP | Sell | 353,194 | $8.38 | $2,959,765.72 | | |
| 4/15/2015 | Joseph B Anderson Jr | Director | Sell | 150,000 | $8.25 | $1,237,500.00 | | |
| 4/13/2015 | Robert K Thompson | EVP | Sell | 95,850 | $8.33 | $798,430.50 | | |
| 4/10/2015 | Douglas E Donley | CAO | Sell | 59,404 | $8.21 | $487,706.84 | | |
| 4/10/2015 | Marcy Syms | Director | Sell | 150,000 | $8.26 | $1,239,000.00 | | |
| 12/29/2014 | Tony Montini | EVP | Sell | 49,525 | $7.47 | $369,951.75 | | |
| 12/23/2014 | Tony Montini | EVP | Sell | 259,750 | $6.92 | $1,797,470.00 | | |
| 12/22/2014 | John T Standley | CEO | Sell | 1,700,000 | $6.82 | $11,594,000.00 | | |
| 12/22/2014 | Kenneth Martindale | COO | Sell | 1,043,400 | $6.80 | $7,095,120.00 | | |
| 12/22/2014 | Robert Ivan Thompson | EVP | Sell | 149,231 | $6.80 | $1,014,770.80 | | |
| 7/3/2014 | Robert Ivan Thompson | EVP | Sell | 249,583 | $7.48 | $1,866,880.84 | | |
| 6/24/2014 | Joseph B Anderson Jr | Director | Sell | 26,667 | $7.05 | $188,002.35 | | |
| 6/23/2014 | Robert Ivan Thompson | EVP | Sell | 510,000 | $7.06 | $3,600,600.00 | | |
| 4/22/2014 | Marc Strassler | EVP | Sell | 224,800 | $7.12 | $1,600,576.00 | 699,369 | |
| 4/21/2014 | Frank Vitrano | EVP | Sell | 1,913,925 | $7.08 | $13,550,589.00 | 1,183,384 | |
| 4/16/2014 | Robert Ivan Thompson | EVP | Sell | 25,566 | $7.03 | $179,728.98 | 749,882 | |
| 2/19/2014 | John Standley | CEO | Sell | 1,200,000 | $6.23 | $7,476,000.00 | 2,974,958 | |
| 2/19/2014 | Kenneth Martindale | COO | Sell | 666,667 | $6.23 | $4,153,335.41 | 1,193,252 | |
| 1/21/2014 | Douglas Donley | SVP | Sell | 24,173 | $5.79 | $139,961.67 | 81,628 | |
| 1/3/2014 | John Standley | CEO | Sell | 600,000 | $5.48 | $3,288,000.00 | 2,974,958 | |
| 1/3/2014 | Kenneth Martindale | COO | Sell | 333,333 | $5.48 | $1,826,664.84 | 1,193,252 | |
| 10/18/2013 | Robert K Thompson | EVP | Sell | 250,000 | $5.27 | $1,317,500.00 | | |
| 10/17/2013 | Douglas E Donley | SVP | Sell | 88,700 | $5.27 | $467,449.00 | | |
| 10/17/2013 | Marc A Strassler | EVP | Sell | 100,000 | $5.31 | $531,000.00 | | |
| 10/14/2013 | Frank Vitrano | CFO | Sell | 1,982,900 | $5.00 | $9,914,500.00 | 1,183,384 | |
| 10/4/2013 | Tony Montini | EVP | Sell | 414,500 | $5.21 | $2,159,545.00 | 643,713 | |
| 9/25/2013 | Robert Ivan Thompson | EVP | Sell | 400,000 | $4.81 | $1,924,000.00 | 749,882 | |
| 7/18/2013 | Robert K Thompson | EVP | Sell | 401,655 | $3.01 | $1,208,981.55 | | |
| 7/16/2013 | David Jessick | Insider | Sell | 100,000 | $2.93 | $293,000.00 | | |
| 7/16/2013 | Marc A Strassler | EVP | Sell | 375,000 | $2.96 | $1,110,000.00 | | |
| 7/12/2013 | Douglas E Donley | SVP | Sell | 6,899 | $2.80 | $19,317.20 | | |
| 7/11/2013 | Douglas E Donley | SVP | Sell | 75,378 | $2.78 | $209,550.84 | | |
| 7/11/2013 | Robert Ivan Thompson | EVP | Sell | 375,000 | $2.75 | $1,031,250.00 | | |
| 6/26/2013 | Jean Coutu Group (Pjc) Inc. | Major Shareholder | Sell | 40,500,000 | $2.75 | $111,375,000.00 | | |
(Data available from 1/1/2013 forward)
Rite Aid (NYSE RAD) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Naloxone available at Rite-Aid without prescription
finance.yahoo.com - April 20 at 3:11 PM |
 | Rite Aid's Merger Still Makes Sense
seekingalpha.com - April 19 at 3:12 PM |
| Naloxone Available at Rite Aid Pharmacies in 19 States
finance.yahoo.com - April 19 at 3:12 PM |
 | Rite Aid (RAD) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 5:30 PM |
| Albertsons Companies, LLC -- Moody's assigns B1 CFR to Albertsons Companies, Inc.; outlook negative
finance.yahoo.com - April 18 at 3:11 PM |
| A Look at Rite Aid’s Fiscal 2019 Guidance
finance.yahoo.com - April 18 at 3:11 PM |
| Mizuho Reiterates Hold Rating for Rite Aid (RAD)
www.americanbankingnews.com - April 18 at 8:42 AM |
| What Drove Down Rite Aid’s Fiscal 4Q18 Sales?
finance.yahoo.com - April 17 at 3:15 PM |
| After Shareholder Backlash, Rite Aid-Albertsons Deal May Get Renegotiated
seekingalpha.com - April 16 at 5:57 AM |
| Short Interest in Rite Aid (RAD) Increases By 11.9%
www.americanbankingnews.com - April 15 at 1:34 AM |
 | Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4
www.zacks.com - April 13 at 3:15 PM |
| Rite Aid: Good News Overlooked
seekingalpha.com - April 13 at 3:15 PM |
| Rite Aid (RAD) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - April 13 at 3:15 PM |
| Zacks Investment Research Lowers Rite Aid (RAD) to Hold
www.americanbankingnews.com - April 13 at 11:45 AM |
| Rite Aid's (RAD) CEO John Standley on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - April 13 at 5:21 AM |
| Rite Aid Shareholders Sour on Albertsons Deal
finance.yahoo.com - April 13 at 5:21 AM |
| Rite Aid up 2% on Q4 results; provides guidance
seekingalpha.com - April 12 at 3:10 PM |
 | UPDATE: Rite Aid tops earnings estimates after completing sale of stores to Walgreens
www.marketwatch.com - April 12 at 3:10 PM |
| Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019
finance.yahoo.com - April 12 at 3:10 PM |
 | Drug retailer Rite Aid's upbeat forecast lifts shares
www.reuters.com - April 12 at 3:10 PM |
| Rite Aid (RAD) Releases FY19 Earnings Guidance
www.americanbankingnews.com - April 12 at 8:55 AM |
| Rite Aid (RAD) Issues Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - April 12 at 8:55 AM |
 | Why Rite Aid Short Interest Continues to Climb Ahead of Merger With Albertsons
www.msn.com - April 11 at 3:15 PM |
| Rite Aid Post Mortem
seekingalpha.com - April 10 at 5:17 AM |
 | Albertsons Withdraws IPO Plan Due To Rite Aid Merger Deal
www.nasdaq.com - April 6 at 3:15 PM |
| Rite Aid (RAD) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 5 at 1:08 AM |
| Rite Aid (RAD) Given a $2.00 Price Target by Royal Bank of Canada Analysts
www.americanbankingnews.com - April 4 at 9:36 PM |
 | Albertsons Clears US Antitrust Hurdle in Acquisition of Drugstore Operator Rite Aid
www.bloomberg.com - April 3 at 3:09 PM |
| Rite Aid-Albertsons Merger Crosses First Antitrust Hurdle
www.zacks.com - April 2 at 3:14 PM |
| Rite Aid to Release Fourth Quarter Results on April 12
finance.yahoo.com - April 2 at 3:14 PM |
| Kroger, Not Albertsons, Should Get Rite Aid
seekingalpha.com - April 1 at 3:13 PM |
| Rite Aid Co. (RAD) Short Interest Update
www.americanbankingnews.com - March 31 at 3:18 AM |
| Rite Aid Announces Results of Offer to Purchase Certain of its Outstanding Series of Notes
finance.yahoo.com - March 30 at 3:13 PM |
| LB-UBS Commercial Mortgage Trust 2006-C6 -- Moody's Affirms Five and Downgrades Two Classes of LBUBS 2006-C6
finance.yahoo.com - March 30 at 5:20 AM |
 | Rite Aid - Albertsons Deal Gets U.S. Regulatory Approval
www.rttnews.com - March 29 at 3:09 PM |
| Rite Aid Announces Expiration of Hart-Scott-Rodino Waiting Period for Merger with Albertsons Companies
finance.yahoo.com - March 29 at 3:09 PM |
| Walgreens: Top Line Grows 12% in Fiscal 2Q18
finance.yahoo.com - March 29 at 3:09 PM |
| Rite Aid (RAD) Completes Agreed Store Transfers to Walgreens
finance.yahoo.com - March 29 at 3:09 PM |
| Rite Aid-Albertsons Deal Clears Key U.S. Antitrust Hurdle
finance.yahoo.com - March 29 at 3:09 PM |
| ReadyCap Commercial Mortgage Trust 2014-1 -- Moody's Upgrades Three and Affirms Two Classes of RCCMT 2014-1
finance.yahoo.com - March 29 at 3:09 PM |
| LB Commercial Mortgage Trust 1999-C1 -- Moody's Upgrades One and Affirms Three Classes of LBCMT 1999-C1
finance.yahoo.com - March 29 at 5:19 AM |
 | Rite Aid (RAD) Completes Transfer of Stores to Walgreens Boots Alliance (WBA)
www.streetinsider.com - March 28 at 3:04 PM |
| Rite Aid (RAD) Upgraded to "Strong-Buy" at Vetr
www.americanbankingnews.com - March 28 at 12:00 AM |
| Walgreens Struggles Despite Being a Healthcare Hub
finance.yahoo.com - March 27 at 3:17 PM |
| Rite Aid Co. (RAD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 5:40 PM |
| Will Rite Aid's (RAD) Soft Sales Hurt Earnings Again in Q4?
finance.yahoo.com - March 22 at 3:21 PM |
 | State AG partners with Penguins, Rite Aid foundations to launch prescription-drug safety program
www.cnbc.com - March 22 at 1:53 PM |
| 'Exhausted' Toys 'R' Us suppliers weigh options as huge retailer shuts - Yahoo Finance
finance.yahoo.com - March 17 at 3:17 PM |
| With An ROE Of 13.22%, Has Rite Aid Corporation’s (NYSE:RAD) Management Done Well?
finance.yahoo.com - March 16 at 3:03 PM |
| CD 2007-CD4 Commercial Mortgage Trust -- Moody's Affirms Three Classes of CD 2007-CD4
finance.yahoo.com - March 16 at 5:03 AM |
Rite Aid (NYSE:RAD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement
Rite Aid (NYSE RAD) Stock Chart for Saturday, April, 21, 2018
Loading chart…
